Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

SPONSORED BY
Related news about the opioid crisis and improving patient outcomes
CPR
EMS providers were ready at the shore, but as they transported the patient, she stopped breathing again and they had to stabilize her
Illicit fentanyl is the biggest driver of the recent rise in U.S. overdose deaths, according to the CDC
The true value of tools like mechanical CPR devices and transport ventilators
“We have no idea where anything was inside or what may have been in there,” Portland Fire Chief David McIntyre
The pharmacy chain is the 12th defendant to settle with the state, which will use the funds to address addiction and overdoses
States including Arizona, Nevada, Maine, Maryland, Wisconsin and North Carolina have removed fentanyl test strips from prohibited lists
Learn more about the real consequences of fentanyl misinformation and educate public safety partners
The award recognizes agencies that have demonstrated creative approaches to improving therapies for patients with Acute Coronary Syndromes and sudden cardiac arrest
A poll of nearly 600 EMS1 readers found that a stunning majority are in favor of providers being able to use medical marijuana if their state allows
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.